Sökning: WFRF:(Sormani Maria Pia) > Neurofilaments as b...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04722naa a2200709 4500 | |
001 | oai:gup.ub.gu.se/337800 | |
003 | SwePub | |
008 | 240913s2024 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:158365303 | |
024 | 7 | a https://gup.ub.gu.se/publication/3378002 URI |
024 | 7 | a https://doi.org/10.1038/s41582-024-00955-x2 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1583653032 URI |
040 | a (SwePub)gud (SwePub)ki | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Khalil, Michael4 aut |
245 | 1 0 | a Neurofilaments as biomarkers in neurological disorders - towards clinical application. |
264 | 1 | c 2024 |
520 | a Neurofilament proteins have been validated as specific body fluid biomarkers of neuro-axonal injury. The advent of highly sensitive analytical platforms that enable reliable quantification of neurofilaments in blood samples and simplify longitudinal follow-up has paved the way for the development of neurofilaments as a biomarker in clinical practice. Potential applications include assessment of disease activity, monitoring of treatment responses, and determining prognosis in many acute and chronic neurological disorders as well as their use as an outcome measure in trials of novel therapies. Progress has now moved the measurement of neurofilaments to the doorstep of routine clinical practice for the evaluation of individuals. In this Review, we first outline current knowledge on the structure and function of neurofilaments. We then discuss analytical and statistical approaches and challenges in determining neurofilament levels in different clinical contexts and assess the implications of neurofilament light chain (NfL) levels in normal ageing and the confounding factors that need to be considered when interpreting NfL measures. In addition, we summarize the current value and potential clinical applications of neurofilaments as a biomarker of neuro-axonal damage in a range of neurological disorders, including multiple sclerosis, Alzheimer disease, frontotemporal dementia, amyotrophic lateral sclerosis, stroke and cerebrovascular disease, traumatic brain injury, and Parkinson disease. We also consider the steps needed to complete the translation of neurofilaments from the laboratory to the management of neurological diseases in clinical practice. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng |
653 | a Humans | |
653 | a Biomarkers | |
653 | a metabolism | |
653 | a blood | |
653 | a Nervous System Diseases | |
653 | a diagnosis | |
653 | a metabolism | |
653 | a blood | |
653 | a Neurofilament Proteins | |
653 | a blood | |
653 | a Intermediate Filaments | |
653 | a metabolism | |
700 | 1 | a Teunissen, Charlotte E4 aut |
700 | 1 | a Lehmann, Sylvain4 aut |
700 | 1 | a Otto, Markus4 aut |
700 | 1 | a Piehl, Fredrik4 aut |
700 | 1 | a Ziemssen, Tjalf4 aut |
700 | 1 | a Bittner, Stefan4 aut |
700 | 1 | a Sormani, Maria Pia4 aut |
700 | 1 | a Gattringer, Thomas4 aut |
700 | 1 | a Abu-Rumeileh, Samir4 aut |
700 | 1 | a Thebault, Simon4 aut |
700 | 1 | a Abdelhak, Ahmed4 aut |
700 | 1 | a Green, Ari4 aut |
700 | 1 | a Benkert, Pascal4 aut |
700 | 1 | a Kappos, Ludwig4 aut |
700 | 1 | a Comabella, Manuel4 aut |
700 | 1 | a Tumani, Hayrettin4 aut |
700 | 1 | a Freedman, Mark S4 aut |
700 | 1 | a Petzold, Axel4 aut |
700 | 1 | a Blennow, Kaj,d 1958u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xbleka |
700 | 1 | a Zetterberg, Henrik,d 1973u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xzethe |
700 | 1 | a Leppert, David4 aut |
700 | 1 | a Kuhle, Jens4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi4 org |
773 | 0 | t Nature Reviews Neurologyg 20:5, s. 269-287q 20:5<269-287x 1759-4758x 1759-4766 |
856 | 4 8 | u https://gup.ub.gu.se/publication/337800 |
856 | 4 8 | u https://doi.org/10.1038/s41582-024-00955-x |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:158365303 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy